Celularity to Present Data Showing Cancer Tumor Reduction by Off-the-Shelf Cell Therapy Derived from Human Placental Cells

FLORHAM PARK, N.J., March 07, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. CELU ("Celularity"), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced today that it will present in vivo data from its T-cell therapy platform at this year's…#celularityinccelu #aacrannualmeeting #celularity #ptcd16vs #roberthariri #adriankilcoyne #sandiego #section21e #tcr #trastuzumab
Source: Reuters: Health - Category: Consumer Health News Source Type: news